Shah Mihir
SEC CIK 1676960 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STLN | Starling Oncology, Inc. | CFO | 474.9K | $127.0K | — | 6 | 2022-05-19 | 2024-05-21 |
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
Shah Mihir made no open-market trades at STLN in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-23 | 2024-05-21 | STLN | Starling Oncology, Inc. | Shah Mihir | CFO | A - Grant | $0.00 | +151.5K | 474.9K | +47% | $0 |
| M | 2023-12-18 | 2023-12-14 | STLN | Starling Oncology, Inc. | Shah Mihir | CFO | P - Purchase | $1.27 | +100.0K | 327.6K | +44% | +$127.0K |
| M | 2023-05-24 | 2023-05-23 | STLN | Starling Oncology, Inc. | Shah Mihir | CFO | D - Sale to Iss | $0.43 | -3,442 | 224.3K | -2% | -$1,480 |
| D | 2023-03-21 | 2023-03-17 | STLN | Starling Oncology, Inc. | Shah Mihir | CFO | A - Grant | $0.00 | +176.2K | 226.9K | +347% | $0 |
| D | 2022-11-21 | 2022-11-17 | STLN | Starling Oncology, Inc. | Shah Mihir | CFO | A - Grant | $0.00 | +18.6K | 50.7K | +58% | $0 |
| D | 2022-05-19 | 2022-05-19 | STLN | Starling Oncology, Inc. | Shah Mihir | CFO | A - Grant | $0.00 | +32.1K | 32.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations